Search for: "Richard Gottlieb" Results 41 - 60 of 163
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
6 Jul 2019, 9:06 pm by Dan Flynn
Former FDA Commissioner Scott Gottlieb supported making store data more public. [read post]
28 May 2019, 4:39 am
Motivated Irrationality (Clarendon Press, 1984).Images: Jackson Pollock, Portrait and a Dream (1953) and Adolph Gottlieb, Phoenix Burst (1973) respectively. [read post]
19 Apr 2019, 6:12 am
Rouhandeh, and Michael Kaplan, Davis Polk & Wardwell LLP, on Saturday, April 13, 2019 Tags: Bonds, Corporate fraud, DOJ, International governance, Misconduct, Rule 144, SEC, SEC enforcement, Securities litigation, Securities regulation, Volkswagen 2019 Proposed Amendments to DGCL Posted by John Mark Zeberkiewicz and Brigitte Fresco, Richards, Layton & Finger, P.A., on Saturday, April 13, 2019 Tags: Appraisal… [read post]
15 Mar 2019, 5:55 am
Wang (Harvard Business School), on Wednesday, March 13, 2019 Tags: Capital allocation, Capital markets, Dividends, Employees, Long-Term value, Public firms, Repurchases, SEC, Securities regulation, Shareholder value, Stakeholders, US Senate SEC Enforcement Against Self-Reporting Token Issuer Posted by Pamela Marcogliese, Matthew Solomon and Alexander Janghorbani, Cleary Gottlieb Steen & Hamilton LLP, on Thursday,… [read post]
21 Dec 2018, 6:00 am
McDonald, Cleary Gottlieb Steen & Hamilton LLP, on Sunday, December 16, 2018 Tags: Boards of Directors, Business judgment rule, Corwin, Delaware cases, Delaware law, Financial reporting, Merger litigation, Mergers & acquisitions, Restatements, Schedule 14D The Prescience of 5% of Investors: A Monsanto Case Study Posted by Sanford Lewis, Shareholder Rights Group, on Monday, December 17, 2018 Tags: Corporate… [read post]
16 Nov 2018, 5:45 am
Tiger, Cleary Gottlieb Steen & Hamilton LLP, on Tuesday, November 13, 2018 Tags: Board independence, Boards of Directors, Conflicts of interest, Controlling shareholders, Delaware cases, Delaware law, DGCL, Listing standards, Management, NYSE, Securities litigation Private Equity Indices Based on Secondary Market Transactions Posted by Michael S. [read post]
15 Nov 2018, 10:00 pm by Bobby Chen
Gottlieb recognized JUUL’s effort but said that its “voluntary action is no substitute for regulatory steps FDA will soon take. [read post]
19 Oct 2018, 6:08 am
Donelson (University of Texas), and Justin Hopkins (University of Virginia), on Thursday, October 18, 2018 Tags: Accounting, Backdating, Disclosure, Information environment, Misreporting, Restatements, Risk, Securities regulation, Stock options, Transparency Making Sense of the Current ESG Landscape Posted by Peter Atkins, Marc Gerber and Richard Grossman, Skadden, Arps, Slate, Meagher & Flom LLP,… [read post]
13 Oct 2018, 9:03 pm by Dan Flynn
FDA Commissioner Scott Gottlieb announced on Sept. 26 the change was in the works. [read post]
20 Jul 2018, 6:14 am
Solomon, Cleary Gottlieb Steen & Hamilton LLP, on Monday, July 16, 2018 Tags: ALJs, Dodd-Frank Act, SEC, SEC enforcement, Securities enforcement, Securities regulation, Supreme Court 2018 Investor Corporate Governance Report Posted by Viraj Patel, CMi2i Proxy, on Tuesday, July 17, 2018 Tags: Board independence, Boards of Directors, Corporate culture, ESG, Human capital, Institutional… [read post]
4 Jul 2018, 11:06 am by Bill Marler
“When the FDA learns about potentially unsafe foods in the marketplace, we must act quickly to keep people from getting sick or being harmed,” Gottlieb wrote. [read post]
3 May 2018, 9:30 pm by Sarah Madigan
Castle and Richard L. [read post]
15 Mar 2018, 9:30 pm by Sarah Madigan
” FDA Commissioner Scott Gottlieb praised the action as “a pivotal step” in reducing cigarette addiction. [read post]
12 Jan 2018, 6:08 am
Alcock, Cleary Gottlieb Steen & Hamilton LLP, on Tuesday, January 9, 2018 Tags: Boards of Directors, Disclosure, Human rights, No-action letters, Rule 14a-8, SEC, Securities regulation, Shareholder proposals, Shareholder voting Compensation Season 2018 Posted by Jeannemarie O’Brien, Adam J. [read post]